PRESS RELEASE Avella Specialty Pharmacyhas once more been called in Inc.

Shanahan, CEO of Avella. At Avella, we attribute a lot of this success to your service-oriented and clinical approach. We continue to concentrate on providing personalized treatment one-on-one with this patients alongside unsurpassed scientific excellence that assists every individual achieve the very best health feasible. Inc. Measures US-based, held privately, for-profit and independent businesses’ development over a 3-calendar year period from 2011 to 2014. Companies acknowledged by Inc. Magazine must match criteria regarding revenue development, and Avella displayed 142 percent during the last three years.CAS Medical Systems, Inc. , today reported first one fourth 2010 revenues of $8.5 million, a rise of $0.1 million, or 1 percent, compared to revenues of $8.4 million for the initial quarter of 2009. The Company reported net income of $0.2 million, or $0.02 per fundamental and diluted common talk about, in comparison to a net loss of $0.9 million, or per basic and diluted common share, reported for the initial quarter of the last year. Revenues for the initial quarter ended March 31, 2010 were led by sales of OEM items and FORE-View monitors and sensors and had been partially offset by reductions in product sales of bedside monitoring products.